List of works - Bruce E Strober

A Delphi Consensus Approach to Challenging Case Scenarios in Moderate-to-Severe Psoriasis: Part 1

scientific article

A Delphi Consensus Approach to Challenging Case Scenarios in Moderate-to-Severe Psoriasis: Part 2.

scientific article published on 30 March 2012

A phase III, randomized, controlled trial of the fully human IL-12/23 mAb briakinumab in moderate-to-severe psoriasis

scientific article published on 20 October 2011

Alefacept for severe alopecia areata: a randomized, double-blind, placebo-controlled study

scientific article published on 01 November 2009

Alefacept for the treatment of psoriasis and other dermatologic diseases

scientific article published on July 2007

Association between biologic therapies for chronic plaque psoriasis and cardiovascular events: a meta-analysis of randomized controlled trials.

scientific article published on August 2011

Benefit-risk profile of tofacitinib in patients with moderate-to-severe chronic plaque psoriasis: pooled analysis across six clinical trials

scientific article published on 10 October 2018

Biopharmaceuticals and biosimilars in psoriasis: What the dermatologist needs to know ⬇️

scientific article published on 01 February 2012

Clinical and Cytological Effects of Pimecrolimus Cream 1% after Resolution of Active Atopic Dermatitis Lesions by Topical Corticosteroids: A Randomized Controlled Trial

scientific article published in 2011

Clinical meaningfulness of complete skin clearance in psoriasis.

scientific article

Comparison of ustekinumab and etanercept for moderate-to-severe psoriasis

scientific article

Comprehensive long-term safety of adalimumab from 18 clinical trials in adult patients with moderate-to-severe plaque psoriasis

scientific article published on 10 October 2018

Consensus guidelines for the management of plaque psoriasis.

scientific article

Core Outcome Sets for Psoriasis Clinical Trials: Definition, Consensus, and Acceptance

scientific article published on 01 October 2018

Cutaneous Bacillus anthracis infection

scientific article published on 8 November 2001

Defining drug-free remission of skin disease in patients with plaque psoriasis

scientific article published on 09 November 2019

Ethical considerations when prescribing biologics in dermatology

scientific article published in September 2012

Folate supplementation during methotrexate therapy for patients with psoriasis

scientific article

Interferon beta-1a-induced morphea.

scientific article

Item-level psychometric properties for a new patient-reported psoriasis symptom diary

scientific article published on September 2013

Management of psoriasis in pregnancy

scientific article published on 01 July 2013

Methotrexate and psoriasis: 2009 National Psoriasis Foundation Consensus Conference

scientific article published on May 2009

Methotrexate and psoriasis: Consensus conference ⬇️

scientific article published on 01 June 2011

National Psoriasis Foundation clinical consensus on disease severity

scientific article

New Therapies for Psoriasis

scientific article published on 01 June 2016

No elevated risk for depression, anxiety or suicidality with secukinumab in a pooled analysis of data from 10 clinical studies in moderate-to-severe plaque psoriasis.

scientific article

Off-label dermatologic uses of anti-TNF-a therapies

scientific article

Pharmacovigilance and biosimilars: considerations, needs and challenges

scientific article published on 26 March 2013

Practice gaps. Methotrexate-induced liver toxicity: replacing the liver biopsy

scientific article published on 01 August 2014

Psoriasis in patients with HIV infection: from the medical board of the National Psoriasis Foundation

scientific article published on 31 July 2009

Secukinumab in pregnancy: outcomes in psoriasis, psoriatic arthritis and ankylosing spondylitis from the global safety database

scientific article published on 11 September 2018

Similar names for similar biologics

scientific article published on 01 October 2014

Substantial alterations of the cutaneous bacterial biota in psoriatic lesions

scientific article

Successful treatment of plaque psoriasis with self-administered subcutaneous alefacept

scientific article published on 01 December 2005

Super‐response to guselkumab treatment in patients with moderate‐to‐severe psoriasis: age, body weight, baseline Psoriasis Area and Severity Index, and baseline Investigator's Global Assessment scores predict complete skin clearance

scientific article published in 2022

Systematic review of the real-world evidence of adalimumab safety in psoriasis registries

scientific article published on 28 August 2018

The Psoriasis Symptom Diary: development and content validity of a novel patient-reported outcome instrument

scientific article published on 4 April 2013

The treatment of moderate-to-severe psoriasis: prescreening and monitoring psoriatic patients on biologics

scientific article published on March 2010

The treatment of psoriasis with etanercept

scientific article

Treatment of atopic dermatitis in pregnancy

scientific article published on July 2013

List of works by Bruce E Strober

A Delphi Consensus Approach to Challenging Case Scenarios in Moderate-to-Severe Psoriasis: Part 1

A Delphi Consensus Approach to Challenging Case Scenarios in Moderate-to-Severe Psoriasis: Part 2.

A phase III, randomized, controlled trial of the fully human IL-12/23 mAb briakinumab in moderate-to-severe psoriasis

Alefacept for severe alopecia areata: a randomized, double-blind, placebo-controlled study

Alefacept for the treatment of psoriasis and other dermatologic diseases

Association between biologic therapies for chronic plaque psoriasis and cardiovascular events: a meta-analysis of randomized controlled trials.

Benefit-risk profile of tofacitinib in patients with moderate-to-severe chronic plaque psoriasis: pooled analysis across six clinical trials

Biopharmaceuticals and biosimilars in psoriasis: What the dermatologist needs to know ⬇️

Clinical and Cytological Effects of Pimecrolimus Cream 1% after Resolution of Active Atopic Dermatitis Lesions by Topical Corticosteroids: A Randomized Controlled Trial

Clinical meaningfulness of complete skin clearance in psoriasis.

Comparison of ustekinumab and etanercept for moderate-to-severe psoriasis

Comprehensive long-term safety of adalimumab from 18 clinical trials in adult patients with moderate-to-severe plaque psoriasis

Consensus guidelines for the management of plaque psoriasis.

Core Outcome Sets for Psoriasis Clinical Trials: Definition, Consensus, and Acceptance

Cutaneous Bacillus anthracis infection

Defining drug-free remission of skin disease in patients with plaque psoriasis

Ethical considerations when prescribing biologics in dermatology

Folate supplementation during methotrexate therapy for patients with psoriasis

Interferon beta-1a-induced morphea.

Item-level psychometric properties for a new patient-reported psoriasis symptom diary

Management of psoriasis in pregnancy

Methotrexate and psoriasis: 2009 National Psoriasis Foundation Consensus Conference

Methotrexate and psoriasis: Consensus conference ⬇️

National Psoriasis Foundation clinical consensus on disease severity

New Therapies for Psoriasis

No elevated risk for depression, anxiety or suicidality with secukinumab in a pooled analysis of data from 10 clinical studies in moderate-to-severe plaque psoriasis.

Off-label dermatologic uses of anti-TNF-a therapies

Pharmacovigilance and biosimilars: considerations, needs and challenges

Practice gaps. Methotrexate-induced liver toxicity: replacing the liver biopsy

Psoriasis in patients with HIV infection: from the medical board of the National Psoriasis Foundation

Secukinumab in pregnancy: outcomes in psoriasis, psoriatic arthritis and ankylosing spondylitis from the global safety database

Similar names for similar biologics

Substantial alterations of the cutaneous bacterial biota in psoriatic lesions

Successful treatment of plaque psoriasis with self-administered subcutaneous alefacept

Super‐response to guselkumab treatment in patients with moderate‐to‐severe psoriasis: age, body weight, baseline Psoriasis Area and Severity Index, and baseline Investigator's Global Assessment scores predict complete skin clearance

Systematic review of the real-world evidence of adalimumab safety in psoriasis registries

The Psoriasis Symptom Diary: development and content validity of a novel patient-reported outcome instrument

The treatment of moderate-to-severe psoriasis: prescreening and monitoring psoriatic patients on biologics

The treatment of psoriasis with etanercept

Treatment of atopic dermatitis in pregnancy